These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Musculoskeletal manifestations of lysosomal storage disorders. Aldenhoven M; Sakkers RJ; Boelens J; de Koning TJ; Wulffraat NM Ann Rheum Dis; 2009 Nov; 68(11):1659-65. PubMed ID: 19822711 [TBL] [Abstract][Full Text] [Related]
26. Postnatal and prenatal diagnosis of lysosomal storage diseases in the former Soviet Union. Krasnopolskaya XD; Mirenburg TV; Akhunov VS; Voskoboeva EY Wien Klin Wochenschr; 1997 Feb; 109(3):74-80. PubMed ID: 9060146 [TBL] [Abstract][Full Text] [Related]
27. Impairment of homeostasis in lysosomal storage disorders. Segatori L IUBMB Life; 2014 Jul; 66(7):472-7. PubMed ID: 25044960 [TBL] [Abstract][Full Text] [Related]
28. Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders. Li W; Cologna SM Mol Omics; 2022 May; 18(4):256-278. PubMed ID: 35343995 [TBL] [Abstract][Full Text] [Related]
30. Newborn screening for lysosomal storage disorders. Meikle PJ; Ranieri E; Ravenscroft EM; Hua CT; Brooks DA; Hopwood JJ Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():104-10. PubMed ID: 11400743 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of lysosomal storage diseases in Portugal. Pinto R; Caseiro C; Lemos M; Lopes L; Fontes A; Ribeiro H; Pinto E; Silva E; Rocha S; Marcão A; Ribeiro I; Lacerda L; Ribeiro G; Amaral O; Sá Miranda MC Eur J Hum Genet; 2004 Feb; 12(2):87-92. PubMed ID: 14685153 [TBL] [Abstract][Full Text] [Related]
32. Current molecular genetics strategies for the diagnosis of lysosomal storage disorders. Giugliani R; Brusius-Facchin AC; Pasqualim G; Leistner-Segal S; Riegel M; Matte U Expert Rev Mol Diagn; 2016; 16(1):113-23. PubMed ID: 26567866 [TBL] [Abstract][Full Text] [Related]
33. Lysosomal storage disorders: molecular basis and laboratory testing. Filocamo M; Morrone A Hum Genomics; 2011 Mar; 5(3):156-69. PubMed ID: 21504867 [TBL] [Abstract][Full Text] [Related]
34. Current strategies in the management of lysosomal storage diseases. Heese BA Semin Pediatr Neurol; 2008 Sep; 15(3):119-26. PubMed ID: 18708002 [TBL] [Abstract][Full Text] [Related]
35. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases. Ramsay SL; Maire I; Bindloss C; Fuller M; Whitfield PD; Piraud M; Hopwood JJ; Meikle PJ Mol Genet Metab; 2004 Nov; 83(3):231-8. PubMed ID: 15542394 [TBL] [Abstract][Full Text] [Related]
36. Extracellular matrix components: an intricate network of possible biomarkers for lysosomal storage disorders? Batzios SP; Zafeiriou DI; Papakonstantinou E FEBS Lett; 2013 Apr; 587(8):1258-67. PubMed ID: 23454643 [TBL] [Abstract][Full Text] [Related]
37. [Thin-layer chromatography of urine oligosaccharides in diagnosis of some lysosomal storage disorders]. Lugowska A; Tylki-Szymańska A; Sawnor-Korszyńska D Pediatr Pol; 1995 Oct; 70(10):847-55. PubMed ID: 8649932 [TBL] [Abstract][Full Text] [Related]
38. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities. Hoffmann B; Mayatepek E Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702 [TBL] [Abstract][Full Text] [Related]